Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Nxera Pharma Co Ltd banner
N

Nxera Pharma Co Ltd
TSE:4565

Watchlist Manager
Nxera Pharma Co Ltd
TSE:4565
Watchlist
Price: 1 299 JPY 2.61% Market Closed
Market Cap: ¥120.3B
Write Note Create Alert Ask AI

Wall St Price Targets

Price Targets Summary
Nxera Pharma Co Ltd

Wall Street analysts forecast Nxera Pharma Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Nxera Pharma Co Ltd is 1 887 JPY with a low forecast of 1 010 JPY and a high forecast of 4 725 JPY.

Lowest Forecast
Wall Street Target
¥1 010
-22% Downside
Average Forecast
Wall Street Target
¥1 887
45% Upside
Highest Forecast
Wall Street Target
¥4 725
264% Upside
Lowest Forecast
Price Target
1 010 JPY
22% Downside
Average Forecast
Price Target
1 887 JPY
45% Upside
Highest Forecast
Price Target
4 725 JPY
264% Upside
Nxera Pharma Co Ltd Competitors:
Price Targets

Revenue
Forecast

20% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
20% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 3 years is 22%.

What are analyst estimates?

Gross Profit
Forecast

16% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
16% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 6 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 23%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Nxera Pharma Co Ltd

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat

What are analyst estimates?

Continue Research

Summary
intrinsic value, competitors valuation, and company profile.
DCF Valuation
stock valuation using Discount Cash Flow valuation method.
Relative Valuation
stock valuation using valuation multiples.
Wall St Estimates
price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Nxera Pharma Co Ltd listings:
OTC • USD
SOLTF
 F • EUR
JSS
 SWB • EUR
JSS
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Nxera Pharma Co Ltd's stock price target?
Price Target
1 887 JPY

According to Wall Street analysts, the average 1-year price target for Nxera Pharma Co Ltd is 1 887 JPY with a low forecast of 1 010 JPY and a high forecast of 4 725 JPY.

What is the Revenue forecast for Nxera Pharma Co Ltd?
Projected CAGR
22%

Over the last 6 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 3 years is 22%.

What is the Gross Profit forecast for Nxera Pharma Co Ltd?
Projected CAGR
23%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 23%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.